Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Operating activities:
Net income	$ 43,071	$ 49,014
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization	22,840	24,646
Amortization of deferred financing costs	671	721
Deferred income taxes	811	(13,004)
Bad debt expense	1,018	906
Stock-based compensation	4,531	3,002
Other non-cash items	(301)	249
Changes in operating items:
Trade receivables	(7,249)	(9,347)
Inventories	14,448	6,956
Prepaid and other	2,675	(45)
Accounts payable and accrued expenses	14,741	1,453
Other assets	(349)	(88)
Other liabilities	98	110
Net cash provided by operating activities	97,005	64,573
Investing activities:
Working capital adjustment related to sale of business		(8,500)
Capital expenditures, net of non-cash expenditures	(16,845)	(15,809)
Net cash used in investing activities	(16,845)	(24,309)
Financing activities:
Acquisition of treasury stock	(14,765)	(12,075)
Proceeds from exercise of employee stock options	929	179
Proceeds from bank borrowings	30,000	30,000
Repayment of bank borrowings	(37,187)	(35,031)
Net cash used in financing activities	(21,023)	(16,927)
Net change in cash and cash equivalents	59,137	23,337
Cash and cash equivalents:
Beginning of period	147,240	149,732
End of period	$ 206,377	$ 173,069